With Jan Stichel at Annette Beck - Sickinger's lab, Leipzig University, Germany and David Weaver, head of the high - throughput screening facilities at Vanderbilt University, I will be screening Vanderbilt's library of small molecules for
potential allosteric modulators of the human Y4 receptor.
Not exact matches
The authors conclude that this newly discovered
allosteric mechanism «suggests that
allosteric modulation in nucleosomes may have biological relevance and
potential for therapeutic interventions.»
Together, our data suggest that clinical studies may be warranted to evaluate the therapeutic
potential of ABL
allosteric inhibitors and to determine whether combination therapies that incorporate these compounds are effective in treating metastatic breast cancer.